Www.ulss.tv.it Advanced brain imaging and neurodegenerative disorders. Dott.ssa Ingrid Inches.

Slides:



Advertisements
Similar presentations
Corpus Callosum Damage Predicts Disability Progression and Cognitive Dysfunction in Primary-Progressive MS After Five Years.
Advertisements

fMRI Methods Lecture 9 – The brain at rest
Imaging Methods: Gait, Cognition and Mood Richard Camicioli MD University of Alberta Edmonton, Alberta
Emmanuel A Stamatakis Centre for Speech, Language and the Brain, Department of Experimental Psychology, University of Cambridge School of Psychological.
Discuss the use of technology in investigating cognitive processes
Public Health Maheen M. Adamson, PhD Director of Clinical Neuroscience, War Related Illness and Injury Study Center (WRIISC) VA Palo Alto Health Care System.
Frontotemporal Dementia
Spatial Neglect and Attention Networks
DTI-Based White Matter Fiber Analysis and Visualization Jun Zhang, Ph.D. Laboratory for Computational Medical Imaging & Data Analysis Laboratory for High.
Significance of White Matter Hyperintensities in MCI Charles DeCarli University of California at Davis Alzheimer’s Disease Center Imaging of Dementia and.
BERG SYMPOSIUM WASHINGTON UNIVERSITY SEPT 2003 MICHAEL W WEINER MD.
Dementia with Lewy Bodies
MCI Clinical Trial Design FDA Advisory Committee Meeting March 13, 2001 Gaithersburg, MD Michael Grundman, MD, MPH Alzheimer’s Disease Cooperative Study.
Alzheimer’s Disease and Biomarkers John H. Dougherty,Jr.M.D. Medical Director Cole Neuroscience Center.
"THE POTENTIAL OF MULTIMODAL MRI FOR UNDERSTANDING SPORTS CONCUSSION" Victoria Morgan, Ph.D., Manus Donahue, Ph.D., Megan Strother, M.D., Allen Sills,
CHAPTER TWO CHAPTER TWO Neuroscience as a Basis for Adult Development and Aging.
Amyotrophic Lateral Sclerosis
Defining Mild Cognitive Impairment Steven T.DeKosky, M.D. Director, Alzheimer’s Disease Research Center University of Pittsburgh Pittsburgh, PA.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Dr Hussein Farghaly PSMMC
Briana Cassetta Kiehl, K. A., et al (2001). Limbic abnormalities in affective processing by criminal psychopaths as revealed by functional magnetic resonance.
Neurological Consequences of Diabetic Ketoacidosis at Initial Presentation of Type 1 Diabetes in a Prospective Cohort Study of Children Featured Article:
BRAIN IMAGING - PERSPECTIVES FOR STUDIES OF PSYCHIATRIC DISORDERS Jair C. Soares, M.D. Division of Mood and Anxiety Disorders, Dept of Psychiatry, University.
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
Age effects on hippocampal functional connectivity during multifeatural encoding Chris Foster 1, Milton Picklesimer 1, Neil Mulligan, Ph.D. 1, and Kelly.
Brain Metabolites in Patients with Asymptomatic Versus Symptomatic HIV-associated neurocognitive disorder: A 7 Tesla MR Spectroscopy Study Mohamed MA,
Are spatial tasks useful for the early diagnosis of Alzheimer’s disease.
INTRODUCTION Chronic pain is associated with cortical functional, neurochemical and morphological changes (Grachev et al., 2002, Apkarian et al., 2004).
Wei Chen CCNI Journal Club Alzheimer’s disease (AD): imaging & cognition imaging & cognition.
Jalal Jalal Shokouhi – MD
CHANGES IN BRAIN MORPHOLOGY ASSOCIATED WITH OBSTRUCTIVE SLEEP APNEA Mary J. Morrell et al Presented by Karen Hu PSYCH 260.
The brain at rest. Spontaneous rhythms in a dish Connected neural populations tend to synchronize and oscillate together.
Fresh Ideas on Architecture of Cognitive Processing and Alzheimer's Disease Pathogenesis: Possibilities for Translation into Clinical Practice Goran Šimić.
High resolution MRI at 21.1 T of the hippocampus and temporal lobe white matter in the differential classification of Alzheimer’s Disease & Diffuse Lewy.
White Matter Structural Integrity in Healthy Aging Adults and Patients With Alzheimer Disease: A Magnetic Resonance Imaging Study Bartzokis, et al. UCLA.
Structural MRI as a Biomarker of Disease Progression in AD Department of Diagnostic Radiology and MRI Research Lab Presented by Clifford Jack, M.D. at.
Apolipoprotein E and Gray Matter Loss in Mild Cognitive Impairment and Alzheimer’s Disease Spampinato MV, Goldsberry G, Mintzer J, Rumboldt Z Medical University.
MEMORY SYSTEMS IN THE BRAIN Some Gross Anatomy. The Human Brain saggital section at midline.
Sven Haller Haller, Nguyen, Rodriguez, Emch, Gold, Bartsch, Lovblad, Giannakopoulos.
T2 FLAIR Increased Signal Intensity at the Posterior Limb of the Internal Capsule: Clinical Significance in ALS Patients G. Protogerou 1, S. Ralli 2, I.
Brain Imaging with MRI MRI of Neuronal Network Structure, Function, and Plasticity Henning U. Voss, Nicholas D. Schiff Progress in Brain Research, Vol.
MULTIMODALITY APPROACH TO IMAGING IN DEMENTIA - ROLE OF MR AND CT PERFUSION AND DTI Marek J. SASIADEK Anna ZIMNY Pawel SZEWCZYK XIX SYMPOSIUM NEURORADIOLOGICUM.
MR SPECTROCOPY AND MRI TO MEASURE TREATMENT OF NEURODEGENERATION MICHAEL W. WEINER Professor of Radiology, Medicine, Psychiatry, and Neurology, U.C.S.F.
Spectroscopy of the Brain in Primary Lateral Sclerosis J. Taylor 4, D. Powell 2,3, H. Chebrolu, 1,3 A. Andersen 2,3, E. Kasarskis 1, C.D. Smith 1,2,3 1.
CASES SERIES BRAIN FDG PET SCAN IN DEMENTIA PATIENTS
A Novel Assessment Tool for Alzheimer's and Frontotemporal Dementias Jeanyung Chey 1,2, Hyun Song 2, Jungsuh Suk 1, & Minue J. Kim 3 The Proportional Reasoning.
Medical Imaging for Neurodegenerative Diseases INFN CdS 7/2011 Giorgio De Nunzio
INFLUENCE OF FRACTIONAL ANISOTROPY THRESHOLD FOR TRACT BASED DIFFUSION TENSOR ANALYSIS OF UNCINATE FASCICLES IN ALZHEIMER DISEASE Toshiaki Taoka, Toshiaki.
DECIDE: "Scientific and Clinical Perspectives“: Claudio Babiloni (UNIFG) and Giovanni Frisoni (IRCCS Brescia)
Radiological imaging of dementia.
Rosa Maria Moresco University of Milan Bicocca
Manuela Tondelli, Gordon K. Wilcock, Paolo Nichelli, Celeste A
CHAPTER TWO Neuroscience as a Basis for Adult Development and Aging
DIFFUSION ABNORMALITY OF CORPUS CALLOSUM IN ALZHEIMER’S DISEASE
Brain Tech TIME Case Study: FDG PET IMAGING IN DEMENTIA (FTD vs AD)
Figure 2 Patterns of brain atrophy in Alzheimer disease
Coronal (above) and axial (below) views of brain imaging findings in selected young onset dementias (images reproduced by kind permission of Dr Hadi Manji.
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
New Face-Name Paradigm for Patients with Mild Alzheimer’s Disease
Memory and Executive Function in Aging and AD
Volume 63, Issue 2, Pages (July 2009)
Michael Ewers, Reisa A. Sperling, William E. Klunk, Michael W
Ajdina Karic and Almira Bogdanic 13th November, 2018
Volume 77, Issue 2, Pages (January 2013)
Biomarker Modeling of Alzheimer’s Disease
Progress Seminar 권순빈.
Joseph I. Friedman et al. JIMG 2014;7:
NEUROIMAGING FINDINGS OF RARE NEURODEGENERATIVE DISEASES RELATED TO DEMENTIA SYMPTOMS INTRODUCTION: Neurodegenerative diseases are diversified group of.
Clinical Concepts Emerging from fMRI Functional Connectomics
Volume 63, Issue 2, Pages (July 2009)
Presentation transcript:

Advanced brain imaging and neurodegenerative disorders. Dott.ssa Ingrid Inches

Neurodegenerative diseases are conventionally diagnosed using clinical assessment, neuropsychology tests and structural neuroimaging. However, there is an increasing need for using advanced mri techniques in order to better assess early volumetric, methabolic, ultrastructural and functional changes. Understanding the pathophysiology of the diseases may help in planning and monitoring therapy.

NEURODEGENERATIVE DISORDERS - DEMENTIAS - EXTRAPYRAMIDAL DISORDERS - MOTOR NEURON DISEASES

Dementias have the gratest impact in health management, among all neurodegenerative disorders. It is characterized by cognitive impairment severe enough to interfere with activity of daily living. Prevalence and incidence of dementias increase with age of patients. 2,5 dementia cases x – 69 yrs 9 dementia cases x – 79 yrs 40, 2 dementia cases x – 89 yrs Ramani, et al., Radiology DEMENTIAS

Prevalence of AD Dementia Scheltens, Fox, Barkhof, DeCarli, Lancet Neurology DEMENTIAS – Alzheimer’s disease

Dubois F, Feldman HF, Jacova C, DeKosky ST et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS – ADRDA criteria. Lancet Neurol 2007; 6: Probable AD: EARLY AND SIGNIFICANT EPISODIC MEMORY IMPAIRMENT CRITERION A: EARLY AND SIGNIFICANT EPISODIC MEMORY IMPAIRMENT at least one or more supportive biomarker criteria.

B. MTL ATROPHY STRUCTURAL NEURO- IMAGING WITH MRI C. GLUCOSE METABOLISM IN BILATERAL TEMPORAL REGIONS MOLECULAR NEURO- IMAGING WITH PET D. β AMYLOID τ PROTEIN CSF ANALYSIS E. PROVEN AUTOSOMAL DOMINANT MUTATION WITHIN THE IMMEDIATE FAMILY SUPPORTIVE CRITERIA at least one or more supportive biomarker criteria.

CONVENTIONAL IMAGING – Alzheimer’s disease CONTROLS AD Linear measures of atrophy in mild Alzheimer disease. Frisoni GB et al. AJNR 17 (1996) ) MTL atrophy is common in AD (71 – 96%) compared with older NC subjects. 2) Width of the temporal horn could discriminate AD vs NC with sensitivity 86%

Mapping local hippocampal changes in Alzheimer’s disease and normal ageing with MRI at 3T. R L L R Frisoni GB,et al. Brain 131 (2008) )sensitive to MTL atrophy in AD not specific 2) sensitive to progression of the disease 3) volumes of AD patients tended to be lower vs NC 4) medial, lateral regions in body and tail were lower in older NC 5) AD dorsolateral head and presubiculum VBM - Alzheimer’s disease

-DTI: white matter damage in AD patients.  MD and  FA in corpus callosum and in WM of frontal, temporal and parietal lobes. Strong correlation between MMSE and WM FA - MD. - In AD patients white matter changes are likely to be secondary to wallerian degeneration due to neuronal loss in cortical areas. DTI - Alzheimer’s disease Bozzali, Falini et al., JNNP 2002.

Diffusion Anisotropy an Diffusivity of White Matter Tracts in the Temporal Stem in AD disease: Evaluation of the “Tract of Interest” by Diffusion Tensor Tractography. T.Taoka, MD; et al. AJNR 27 (2006) NC and 15 AD “tract of interest” method TRACTS - Alzheimer’s disease

Regional Degradation of White Matter Ultrastructure in Mild cognitive impairment and Alzheimer’s disease by Diffusion Tensor Imaging. Y. Zhang, MD; et al. Neurology 68 (2007 ) Alzheimer’s disease and MCI -MCI is associated with FA reduction particularly in the cingulum fibers, predominantly in the left posterior cingulate. -In AD, FA is further reduced in the cingulum fibers and FA reduction extend to the splenium. -FA reduction in the posterior cingulate improved the classification of MCI and AD from cognitively normal elderly, compared to the classifications using hippocampal volume loss alone.

Regionally-specific diffusion tensor imaging in Mild cognitive impairment and Alzheimer’s disease. M.M.Mielke, MD; et al. Neuroimage 46 (2009) pts (25 NC, 25 aMCI, 25 AD) -baseline and 3 months follow up -AD vs NC reduction FA in fornix and anterior cingulate -MCI vs AD lower FA in fornix, anterior cingulate, splenium -Over 3 months follow- up further decrease FA in anterior cingulate -Decrease FA well correlated with worse clinical performance. Alzheimer’s disease and MCI

A diffusion tensor MRI study of patients with MCI an AD with a 2-year clinical follow-up. Scola E, Bozzali M, Agosta F, Falini A et al. J Neurol Neurosur Psychiatry ; 798 – pts (21 aMCI, 21 AD, 20 NC) - baseline and 2 years follow up - aMCI-C had WM and GM changes similar to AD - aMCI-NC showed DTI pattern similar to NC - increase MD in hippocampi, anterior insulae, frontal and parietal WM and decrease FA of temporal WM better distinguished aMCI-C vs aMCI-NC Alzheimer’s disease and MCI

Whole-brain N-Acetylaspartate as a surrogate Marker of Neuronal Damage in diffuse Neurologic Disorders. D.J. Rigotti et al. AJNR 28 (2007) NAA (single peak at 2.02) is the most intense in a healthy brain NC, 28 AD, 27 MCI significant decrease of WB NAA AD vs NC but not between them (MCI – AD). H MRS - Alzheimer’s disease

MCI AD H MR spectroscopy voxel in posterior cingulate, superior-temporal and parietal lobe. -Decrease of NAA peak and increase of Myo peak in AD and MCI vs NC. -Increase of Myo peak in MCI vs NC Kaantarci, Reynolds et al., AJNR Alzheimer’s disease and MCI

- fMRI testing the activation of MTL memory - learning tasks that required the encoding of new information into memory (familiar pictures vs novel pictures) -12 AD 10 NC - Decrease functional signal in MTL areas in AD vs NC Functional MR imaging in Alzheimer’s Disease during Memory Encoding. S. Rombouts, F. Barkhof et al. AJNR 21 (2000) fMRI - Alzheimer’s disease

Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. B.C. Dickerson, MD et al. Neurology 65 (2005) NC, 9 MCI, 10 AD - fMRI with face-name task - Hyperactivation in hippocampal and entorhinal cortex in MCI - This pattern may reflect the need for memory circuits to recruit additional neural resources in order to compensate early MTL memory – networks degeneration. Alzheimer’s disease and MCI

-75 subjects - 13 AD - 28 NC - face–name associative memory encoding task : novel face – name pairs familiar face – name pairs  in signal intensity magnitude from NC, MCI, AD in - left anterior cingulate gyrus - left MTL ( hyppocampus)  in signal magnitude from NC, MCI, AD in postero-medial cortices (precuneus and posterior cyngulate gyrus). Cortical Deactivation in Mild Cognitive Impairment: High – Field – Strength Functional MR Imaging. J Petrella, MD et al. Radiology 245 (2007) 224 – 235. Alzheimer’s disease and MCI

- Increasing magnitude activation signal from NC to MCI to AD in PMC - Loss of deactivation in PMC: abnormally activation in low default mode network activity region. - PMC: region attending to enviromental stimuli, planning future behaviors and conscious processes.

- 41 NC, 18 AD, 28 MCI - MCI patients less deactivation vs NC but more vs AD - Anterior frontal cortex default mode network distinguished MCI from NC and AD. - The response in the precuneus NC vs AD and MCI not MCI vs AD. Altered resting state networks in mild cognitive impairment and mild Alzheimer’s disease: an fMRI study. SA Rombouts, F Barkhof et al. Radiology 256 (2010) 598 – 606. fMRI resting state - Alzheimer’s disease and MCI

Post-mortem biochemical studies ( Connor et al, Neurobiol Aging 2004 ) found out eccessive brain iron in cortical and basal ganglia region in AD. SWI - Alzheimer’s disease Oxidative damage to the brain caused by free radical reactions catalized by iron could be implicated in AD.

In AD entorhinal cortex could be a marker of iron. SWI has been proposed as a means of measuring regional iron level.

Structural imaging based on magnetic resonance is an integral part of the clinical assessment of patients with suspected Alzheimer dementia. Diffusion tensor, functional magnetic resonance imaging, and resting/functional MRI have a relevant role as adjuncts to clinical assessment in early diagnosis and monitoring of progression. New growing interest in SWI-dependent imaging as a potential bio- marker of the presence of iron in AD. Conclusions

-75 subjects - 13 AD - 28 NC - face–name associative memory encoding task : novel face – name pairs familiar face – name pairs  in signal intensity magnitude from NC, MCI, AD in - left anterior cingulate gyrus - left MTL ( hyppocampus)  in signal magnitude from NC, MCI, AD in postero-medial cortices (precuneus and posterior cyngulate gyrus). Cortical Deactivation in Mild Cognitive Impairment: High – Field – Strength Functional MR Imaging. J Petrella, MD et al. Radiology 245 (2007) 224 – 235. Alzheimer’s disease and MCI

DEMENTIAS – Alzheimer disease Conventionally neurodegenerative diseases are diagnosed using clinical assessment, neuropsychology and structural neuroimaging. However there in an increasing need for using advanced mri technique in order to better asses early volumetric, methabolic, ultrastuctural and functional changes helping to understand the pathophysiology of the diseases and planning and monitoring therapy.